Schedule
This program is among the highest-rated Harvard Medical School CME courses.
All agenda sessions are in Eastern Time.
Please note that program changes/substitutions may be made without notice.
Monday, May 4, 2026
Welcome and Introduction
Dr. A. Enrique Caballero
9:00-9:15 am
Type 1 Diabetes: What Is New?
Screening, Diagnosis, and Staging of the Disease
Dr. Bruce Perkins
9:15-9:40 am
Prevention and Treatment of Type 1 Diabetes: An Update
Dr. Irl Hirsch
9:40-10:05 am
Panel Discussion and Practical Recommendations
Drs. Perkins and Hirsch
10:05-10:45 am
Break
10:45-11:00
Lifestyle Modification in Diabetes, Obesity, and Related Disorders
What Do I Tell My Patient to Eat?
Laura Andromalos, MS, RD, RN, CDCES
11:00-11:25 am
Get the Patient Moving! Exercise Recommendations
Jacqueline Shahar, MEd, RCEP, DCES
11:25-11:50 am
Panel Discussion and Practical Recommendations
Laura Andromalos, MS, RD, RN, CDCES and Jacqueline Shahar, MEd, RCEP, DCES
11:50 am-12:30 pm
Break
12:30-1:20 pm
Incorporating Technological Advances in Diabetes Care
Continuous Glucose Monitoring: For Everyone with Diabetes?
Dr. Devin Steenkamp
1:20-1:45 pm
Is There a Role in Incorporating Technological Advances for People with Prediabetes or Normal Glucose Levels?
Dr. Jorge Rodriguez
1:45-2:10 pm
Panel Discussion and Practical Recommendations
Drs. Steenkamp and Rodriguez
2:10-2:50 pm
Break
Special Lecture
The Past, Present, and Future of Diabetes Care
Dr. A. Enrique Caballero
3:00-3:45 pm
Tuesday, May 5, 2026
Welcome, Recap, and Introduction to Day 2
Dr. A. Enrique Caballero
9:00-9:10 am
Obesity as the Focus for the Prevention and Treatment of Diabetes and Related Disorders
Understanding Overweight and Obesity as a Disease
9:10-9:40 am
Obesity and Cancer: Are They Truly Related?
Dr. Jennifer Ligibel
9:40-10:10 am
Obesity and Arthritis: Is It Just More Weight on the Joints?
Dr. Deborah Horan
10:10-10:50 am
Break
10:50-11:05 am
The Emotional and Psychological Impact of Obesity
Dr. Nina Crowley
11:05-11:35 am
Panel Discussion and Practical Recommendations
Drs. Ligibel, Horan, and Crowley
11:35 am-12:15 pm
Break
12:15-1:05 pm
Prevention and Treatment of Obesity: A Hot Debate
Pharmacological Management of Obesity
Dr. Jaime Almandoz
1:05-1:45 pm
Surgical Management of Obesity
Dr. Matt Hutter
1:45-2:30 pm
Q and A and Practical Recommendations
Drs. Almandoz and Hutter
2:30-3:00 pm
Special Lecture
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2026 Vision
Dr Ken Cusi
3:00-3:45 pm
Wednesday, May 6, 2026
Welcome, Recap of Day 2 and Introduction to Day 3
Dr. A. Enrique Caballero
9:00-9:10 am
Cardiovascular Disease in the Patient with Diabetes
Evaluating Cardiovascular Risk: The Role of CRP, Lp(a), Apo B and Calcium Scores
Dr. Michael Blaha
9:10-9:40 am
Evaluation and Management of Congestive Heart Failure
9:40-10:10 am
Q and A and Practical Recommendations
Dr. Michael Blaha
10:10-10:45 am
Break
10:45-11:00 am
Hypertension and Dyslipidemia Management in the Patient with Diabetes
Hypertension: Evaluation, Goals, and Current Treatment Recommendations
Dr. Naomi Fisher
11:00-11:25 am
Dyslipidemia: Targets and Management Guidelines
Dr. Om Ganda
11:25-11:50 am
Q and A and Practical Recommendations
Drs. Fisher and Ganda
11:50 am-12:30 pm
Break
12:30-1:20 pm
Chronic Kidney Disease in Diabetes and Metabolic Care
The Need to Thoroughly Evaluate Kidney Function: Why and How?
1:20-1:50 pm
Treatment of Chronic Kidney Disease: What Do the Guidelines Say?
Dr. Janani Rangaswami
1:50-2:20 pm
Q and A and Practical Recommendations
Dr. Rangaswami
2:20-2:50 pm
Break
2:50-3:00 pm
Special Lecture
Artificial Intelligence in Diabetes Care: Fact or Fiction?
Janice MacLeod, MA, RD, CDCES, FADCES
3:00-3:45 pm
Thursday, May 7, 2026
Welcome, Recap of Day 3, and Introduction to Day 4
Dr. A. Enrique Caballero
9:00-9:10 am
Improving Diabetes Care in the Trenches
What We All Can Do to Improve the Lives of Everyone with the Disease
Opportunities to Improve Diabetes Care in Your Community
Dr. Osagie Ebekozien
9:10-9:40 am
Question and Answer Session
Dr. Ebekozien
9:40-10:10 am
Pharmacological Management of Diabetes: Traditional Medications
Insulin Therapy in the Patient with Diabetes
10:10-10:40 am
Break
10:40-10:55 am
Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)
Dr. Deborah Wexler
10:55-11:25 am
Q and A and Practical Recommendations
Dr. Wexler
11:25 am-12:00 pm
Break
12:00-1:00 pm
Pharmacological Management of Type 2 Diabetes: SGLT-2 Inhibitors and GLP-1-Based Therapies
Perspectives from Different Medical Specialties
SGLT-2 Inhibitors: An Update from a Cardiologist's Perspective
Dr. Deepak Bhatt
1:00-1:35 pm
GLP-1 Receptor Agonists: An Update from an Obesity/Diabetes Perspective
Dr. Caroline Apovian
1:35-2:10 pm
Mineralocorticoid Receptor Antagonists: An Update from a Nephrologist's Perspective
Dr. Romela Petrosyan
2:10-2:45 pm
Q and A and Practical Recommendations
Drs. Bhatt, Apovian, and Petrosyan
2:45-3:00 pm
Closing Remarks
Dr. A. Enrique Caballero
3:30-3:40 pm